PathoVax

Utilizing Virus-Like Particles for the prevention & treatment of cancers

[PathoVax @PathoVax]

Immune-based approaches that could block the development of skin cancer by boosting immunity against the commensal HPVs present in all of our skin https://t.co/sx1XxXRmgZ

[Tammi Thomas @tammithomas]

.@PathoVax is an early stage biotech start-up company that was spun out of .@JohnsHopkins (& a .@MDTEDCO portfolio company). Vision: Develop a new generation of safe, efficacious medicines for the prevention & treatment of emerging infectious disease & cancers. Join them today!

[PathoVax @PathoVax]

We’re pleased to have a presence back in Boston as part of the @JLABS family #JPODSBoston #innovation

[JHTV @JHTechVentures]

Congrats to the leaders of @Sonavex, @SisuGlobal, @GemstoneBio, @PathoVax, Avidea Technologies, @the_clearmask and Renalert for being named some of Baltimore's Top 10 BioHealth Startup CEOs by @BioBuzzMaryland! https://t.co/RSto3optUN

[PathoVax @PathoVax]

PathoVax will be at #AACR2019!! Come check out our late breaking poster presentation this Tuesday morning (April 2nd) on our next generation HPV vaccine! Poster#18 Section #42

[Judy Costello @judycostello]

Congrats Joshua and team! @NCIsbir #HPVvaccine @JHTechVentures #SBIR

[TEDCO @MDTEDCO]

Congratulations to @MDTEDCO Maryland Innovation Initiative portfolio company .@PathoVax! They have secured another SBIR Phase 1 worth $300K from the .@theNCI.

[Arti Santhanam @ArtiSanthanam]

Congratulations to @MDTEDCO #MII portfolio company @PathoVax on successful strides towards #vaccine commercialization

[PathoVax @PathoVax]

PathoVax secures another SBIR Ph1 worth $300K from the NCI to imbue thermostable and single-dose properties into our HPV vaccine-RGVax. This new formulation will potentiate the world’s 1st single- immunization, thermostable, broad-spectrum Human Papillomavirus (HPV) Vaccine!!

[PathoVax @PathoVax]

PathoVax LLC is looking to hire! Contact us if you or someone you know might be a fit for either our Platform Discovery Scientist/Sr Scientist or Research Associate Scientist positions!! https://t.co/HnZP4U4tTL

[National Cancer Institute @theNCI]

Vaccination with #HPV vaccines is the best way to prevent several types of cancer, including some throat cancers: https://t.co/cF2z3hqM5h

[PathoVax @PathoVax]

1st PathoVax Annual Christmas Party! 🎄 Here’s to many more years to come! #Christmas #TeamPhoto #Vaccines #GrowingTeam

[Pava Marie LaPere Center for Entrepreneurship @PavaCenter]

Congrats PathoVax!! JHU startup PathoVax raises $2.75M, grows team https://t.co/5huj4I9uxe via @TechnicallyBMR

[Maryland Tech Council @MDTechCouncil]

#MTCVMS Mentee Company and JHU startup PathoVax raises $2.75M, grows team https://t.co/ADVXrfu0eX via @TechnicallyBMR @PathoVax

[JHTV @JHTechVentures]

Congrats @PathoVax 🙌

[PathoVax @PathoVax]

Another article about our Series A1! Looking forward to achieving success! https://t.co/M4zbnfemMR

[PathoVax @PathoVax]

@PathoVax raises $2.75 million Series A1 https://t.co/O5TayzRIWe via @BaltBizOnline

[PathoVax @PathoVax]

Today’s #IPVC2018 plenary lecture! Acting Director of NCI Doug Lowy mentions the RG-1 VLP technology as a promising approach to target neglected HPV types !! #FightHPVTogether

[PathoVax @PathoVax]

We’re here at the #IPVC2018! If you missed our talk yesterday! No worries, Check out our poster or remaining talk on our vaccine antibody mechanism of protection this Saturday!#FightHPVTogether

[JHTV @JHTechVentures]

Congrats! https://t.co/VF6drgROB4